These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


408 related items for PubMed ID: 30353299

  • 1. Calcitriol treatment in patients with low vitamin D levels.
    Tanakol R, Gül N, Üzüm AK, Aral F.
    Arch Osteoporos; 2018 Oct 23; 13(1):114. PubMed ID: 30353299
    [Abstract] [Full Text] [Related]

  • 2. Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d3 or calcitriol treatment: Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China.
    Liao EY, Zhang ZL, Xia WB, Lin H, Cheng Q, Wang L, Hao YQ, Chen DC, Tang H, Peng YD, You L, He L, Hu ZH, Song CL, Wei F, Wang J, Zhang L.
    Medicine (Baltimore); 2018 Aug 23; 97(31):e11694. PubMed ID: 30075569
    [Abstract] [Full Text] [Related]

  • 3. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ.
    J Bone Miner Res; 2004 Aug 23; 19(8):1221-30. PubMed ID: 15231008
    [Abstract] [Full Text] [Related]

  • 4. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS).
    Kärkkäinen M, Tuppurainen M, Salovaara K, Sandini L, Rikkonen T, Sirola J, Honkanen R, Jurvelin J, Alhava E, Kröger H.
    Osteoporos Int; 2010 Dec 23; 21(12):2047-55. PubMed ID: 20204604
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of risedronate with cholecalciferol on bone mineral density in Korean patients with osteoporosis.
    Park SY, Kang MI, Park HM, Rhee Y, Moon SH, Yoon HK, Koh JM, Chang JS, Kim IJ, Won YY, Park YS, Choi H, Shin CS, Yoon TR, Yun SC, Chung HY, IDEAL Trial Investigators.
    Arch Osteoporos; 2019 Dec 09; 15(1):3. PubMed ID: 31820121
    [Abstract] [Full Text] [Related]

  • 6. Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal.
    Liao EY, Zhang ZL, Xia WB, Lin H, Cheng Q, Wang L, Hao YQ, Chen DC, Tang H, Peng YD, You L, He L, Hu ZH, Song CL, Wei F, Wang J, Zhang L.
    BMC Musculoskelet Disord; 2018 Jul 03; 19(1):210. PubMed ID: 29970059
    [Abstract] [Full Text] [Related]

  • 7. Physical performance and life quality in postmenopausal women supplemented with vitamin D: a two-year prospective study.
    Gao LH, Zhu WJ, Liu YJ, Gu JM, Zhang ZL, Wang O, Xing XP, Xu L.
    Acta Pharmacol Sin; 2015 Sep 03; 36(9):1065-73. PubMed ID: 26279157
    [Abstract] [Full Text] [Related]

  • 8. Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial.
    Hansen KE, Johnson RE, Chambers KR, Johnson MG, Lemon CC, Vo TN, Marvdashti S.
    JAMA Intern Med; 2015 Oct 03; 175(10):1612-21. PubMed ID: 26237520
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of cholecalciferol and calcitriol on calcium metabolism and bone turnover in Chinese postmenopausal women with vitamin D insufficiency.
    Zhang H, Huang QR, Gu JM, Hu WW, Liu YJ, Hu YQ, Zhang ZL.
    Acta Pharmacol Sin; 2012 Apr 03; 33(4):490-5. PubMed ID: 22407227
    [Abstract] [Full Text] [Related]

  • 10. The effect of cholecalciferol and calcitriol on biochemical bone markers in HIV type 1-infected males: results of a clinical trial.
    Bang UC, Kolte L, Hitz M, Schierbeck LL, Nielsen SD, Benfield T, Jensen JE.
    AIDS Res Hum Retroviruses; 2013 Apr 03; 29(4):658-64. PubMed ID: 23199009
    [Abstract] [Full Text] [Related]

  • 11. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
    Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A.
    Clin J Am Soc Nephrol; 2010 May 03; 5(5):905-11. PubMed ID: 20203163
    [Abstract] [Full Text] [Related]

  • 12. A randomized double-blind placebo-controlled trial of vitamin D supplementation in juvenile-onset systemic lupus erythematosus: positive effect on trabecular microarchitecture using HR-pQCT.
    Lima GL, Paupitz JA, Aikawa NE, Alvarenga JC, Pereira RMR.
    Osteoporos Int; 2018 Mar 03; 29(3):587-594. PubMed ID: 29152675
    [Abstract] [Full Text] [Related]

  • 13. Relationship between increased endogenous parathormone levels and bone density in postmenopausal women treated with bisphosphonates.
    Coin A, Veronese N, Bolzetta F, De Rui M, Manzato E, Sergi G.
    Panminerva Med; 2012 Dec 03; 54(4):277-82. PubMed ID: 23123579
    [Abstract] [Full Text] [Related]

  • 14. Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?
    Mela Q, Ruggiero V, Montaldo L, Pisano U, Matta L, Maria Pasetto C, Onali S, Cacace E, Carta MG, Barca L, Chessa L.
    HIV Clin Trials; 2018 Oct 03; 19(5):188-196. PubMed ID: 30445888
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D insufficiency does not affect response of bone mineral density to alendronate.
    Antoniucci DM, Vittinghoff E, Palermo L, Black DM, Sellmeyer DE.
    Osteoporos Int; 2009 Jul 03; 20(7):1259-66. PubMed ID: 19043656
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.
    Sakai A, Ito M, Tomomitsu T, Tsurukami H, Ikeda S, Fukuda F, Mizunuma H, Inoue T, Saito H, Nakamura T, e-ADVANCED Study Group.
    Osteoporos Int; 2015 Mar 03; 26(3):1193-202. PubMed ID: 25592133
    [Abstract] [Full Text] [Related]

  • 17. Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women.
    Park JH, Park KH, Cho S, Choi YS, Seo SK, Lee BS, Park HS.
    Menopause; 2013 Jul 03; 20(7):747-53. PubMed ID: 23511701
    [Abstract] [Full Text] [Related]

  • 18. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Jul 03; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 19. The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients.
    van den Bout-van den Beukel CJ, van den Bos M, Oyen WJ, Hermus AR, Sweep FC, Tack CJ, Bosch ME, Burger DM, Koopmans PP, van der Ven AJ.
    HIV Med; 2008 Oct 03; 9(9):771-9. PubMed ID: 18754805
    [Abstract] [Full Text] [Related]

  • 20. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
    Cesareo R, Di Stasio E, Vescini F, Campagna G, Cianni R, Pasqualini V, Romitelli F, Grimaldi F, Manfrini S, Palermo A.
    Osteoporos Int; 2015 Apr 03; 26(4):1295-302. PubMed ID: 25524023
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.